Skip to Content

DB03 (Letrozole 2.5 mg)

Pill with imprint DB03 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by APP Pharmaceuticals, LLC.

Letrozole is used in the treatment of breast cancer, metastatic; breast cancer; breast cancer, adjuvant and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DB03

Letrozole

Imprint
DB03
Strength
2.5 mg
Color
Yellow
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Aromatase inhibitors, Hormones/antineoplastics
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
APP Pharmaceuticals, LLC
National Drug Code (NDC)
63323-0772
Inactive Ingredients
silicon dioxide colloidal, hypromelloses, lactose monohydrate, magnesium stearate, corn starch, microcrystalline cellulose, polyethylene glycol, sodium starch glycolate type A potato, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.